An Observational Study to Describe the Effectiveness of Angiotensin Converting Enzyme Inhibitor and Calcium Channel Blocker Combination in the Management of Hypertensive Patients With Elevated Heart Rate and Type 2 Diabetes

CompletedOBSERVATIONAL
Enrollment

270

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

March 8, 2016

Conditions
Hypertension
Trial Locations (23)

6170

Yıldırım Beyazıt University Yenimahalle Training and Research Hospital, Ankara

10000

Research facility ID ORG-001116, Balıkesir

15300

Research facility ID ORG-001112, Burdur

19200

Research facility ID ORG-001123, Çorum

25040

Erzurum Regional Training and Research Hospital, Erzurum

25080

Atatürk University Aziziye Research Hospital, Erzurum

34098

Research facility ID ORG-001118, Istanbul

34147

Bakırköy Dr. Sadi Konuk Training and Research Hospital, Istanbul

34303

Research facility ID ORG-001117, Istanbul

34662

Uskudar PublicHospital, Üsküdar

34668

Dr. Siyami Ersek Göğüs Kalp ve Damar Cerrahisi Training and Research Hospital, Istanbul

34920

Research facility ID ORG-001125, Istanbul

42250

Research facility ID ORG-001110, Konya

61800

Research facility ID ORG-001122, Trabzon

67900

Research facility ID ORG-001124, Zonguldak

71400

Research facility ID ORG-001115, Kırıkkale

77000

Yalova Public Hospital, Yalova

78100

Research facility ID ORG-001113, Karabük

01330

Research facility ID ORG-001108, Adana

06230

Research facility ID ORG-001030, Ankara

07059

Research facility ID ORG-001111, Antalya

09020

Research facility ID ORG-001120, Aydin

09100

Research facility ID ORG-001119, Aydin

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

MonitorCRO

INDUSTRY

lead

Abbott

INDUSTRY